1. Skeletal muscle non-shivering thermogenesis as an attractive strategy to combat obesity.
- Author
-
Li H, Wang C, Li L, and Li L
- Subjects
- Adenosine Triphosphate metabolism, Animals, Biological Products chemistry, Biological Products pharmacology, Biological Products therapeutic use, Humans, Muscle, Skeletal drug effects, Obesity drug therapy, Sarcoplasmic Reticulum Calcium-Transporting ATPases metabolism, Muscle, Skeletal physiopathology, Obesity physiopathology, Thermogenesis drug effects
- Abstract
Obesity is a chronic disease derived from disequilibrium between energy intake and energy expenditure and evolving as a challenging epidemiological disease in the 21st century. It is urgently necessary to solve this issue by searching for effective strategies and safe drugs. Skeletal muscle could be a potential therapeutic target for the prevention and treatment of obesity and its associated complications due to non-shivering thermogenesis (NST) function. Skeletal muscle NST is based dominantly on futile sarcoplasmic reticulum Ca
2+ ATPase (SERCA) pump cycling that leads to a rise in cytosolic Ca2+ , increased adenosine triphosphate (ATP) hydrolysis and heat production. This review will highlight the mechanisms of skeletal muscle NST, including SLN mediated SERCA pump futile cycling, SR-mitochondrial crosstalk and increased mitochondrial biogenesis, and thermogenesis induced by uncoupling proteins 3 (UCP3). We then summarize natural products targeting the pathogenesis of obesity via skeletal muscle NST, offering new insights into pharmacotherapy and potential drug candidates to combat obesity., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2021
- Full Text
- View/download PDF